Lindbrook Capital, LLC Mei Pharma, Inc. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$2.33 - $3.37 $4,660 - $6,740	-2,000 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$2.6 - $3.65 $28 - $40	-11 Reduced 0.55%	2,000 $6,000
Q4 2020 Jan 27, 2021	SELL	$2.6 - $3.32 $6,500 - $8,300	-2,500 Reduced 55.42%	2,011 $5,000
Q3 2020 Nov 03, 2020	BUY	$2.46 - $4.27 $4,477 - $7,771	1,820 Added 67.63%	4,511 $14,000
Q2 2020 Jul 27, 2020	BUY	$1.45 - $4.3 $2,451 - $7,271	1,691 Added 169.1%	2,691 $11,000
Q4 2019 Jan 27, 2020	SELL	$1.65 - $2.48 $8,250 - $12,400	-5,000 Reduced 83.33%	1,000 $2,000
Q2 2019 Jul 24, 2019	BUY	$2.45 - $3.32 $12,250 - $16,600	5,000 Added 500.0%	6,000 $15,000
Q4 2018 Feb 07, 2019	BUY	$1.92 - $4.1 $1,920 - $4,100	1,000 New	1,000 $2,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.